We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pharma Co. Slams Patent Challenge Standing In Fed. Circ.

Law360, Washington (December 5, 2017, 9:53 PM EST) -- Pharmaceuticals company Bristol-Myers Squibb Co. asked the Federal Circuit Tuesday to reject for lack of standing a competitor’s appeal of a U.S. Patent Trial and Appeal Board decision upholding its patent for a biologics product, saying the company cannot show injury because it has not yet developed a product that infringes the patent.

Momenta Pharmaceuticals Inc. has no standing to appeal the PTAB’s decision upholding Bristol-Myers’ patent for stable liquid formulations of the protein CTLA4Ig, because the company is years away from developing a marketable competing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.